DENALI THERAPEUTICS INC's ticker is DNLI and the CUSIP is 24823R105. A total of 188 filers reported holding DENALI THERAPEUTICS INC in Q1 2022. The put-call ratio across all filers is 2.00 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2022 | $887,000 | -38.7% | 27,557 | -15.1% | 0.00% | -100.0% |
| Q4 2021 | $1,447,000 | -13.1% | 32,444 | -1.7% | 0.00% | 0.0% |
| Q3 2021 | $1,665,000 | -66.9% | 32,998 | -48.6% | 0.00% | -66.7% |
| Q2 2021 | $5,037,000 | +101.3% | 64,209 | +46.5% | 0.00% | +200.0% |
| Q1 2021 | $2,502,000 | -35.6% | 43,819 | -5.6% | 0.00% | -50.0% |
| Q4 2020 | $3,888,000 | +92.4% | 46,415 | -17.7% | 0.00% | +100.0% |
| Q3 2020 | $2,021,000 | +410.4% | 56,417 | +244.2% | 0.00% | – |
| Q2 2020 | $396,000 | +90.4% | 16,390 | +38.0% | 0.00% | – |
| Q1 2020 | $208,000 | 0.0% | 11,876 | -0.4% | 0.00% | – |
| Q4 2019 | $208,000 | +10.6% | 11,922 | -2.8% | 0.00% | – |
| Q3 2019 | $188,000 | – | 12,266 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Crestline Management, LP | 19,462,500 | $339,037,000 | 35.95% |
| Euclidean Capital LLC | 323,749 | $27,117,000 | 5.74% |
| Flagship Pioneering Inc. | 2,730,263 | $228,687,000 | 4.16% |
| Casdin Capital, LLC | 1,310,000 | $109,726,000 | 3.25% |
| A.R.T. Advisors, LLC | 6,173 | $517,000 | 2.39% |
| MARK ASSET MANAGEMENT LP | 172,040 | $14,410,000 | 1.73% |
| Temasek Holdings (Private) Ltd | 4,410,457 | $369,420,000 | 1.59% |
| Integral Health Asset Management, LLC | 57,500 | $4,816,000 | 1.43% |
| GILDER GAGNON HOWE & CO LLC | 3,219,843 | $269,694,000 | 1.34% |
| IRONWOOD INVESTMENT MANAGEMENT LLC | 19,365 | $1,622,000 | 0.95% |